Sarepta FDA Shipment Halt - Search News

Order byBest matchMost fresh

News

Sarepta Will Resume Gene Therapy Shipments

· 13h · on MSN

Sarepta resumes shipping of gene therapy Elevidys to patients who can walk

Sarepta Therapeutics said on Monday it will resume shipping of its gene therapy Elevidys to patients with a rare muscular disorder who can walk, after the FDA recommended the removal of a voluntary hold that was placed on the therapy.

Continue reading

Sarepta shares soar 36% after FDA clears partial resumption of Elevidys shipments

· 14h · on MSN

Sarepta will resume gene therapy shipments after FDA review of recent patient death

7d

Sarepta Therapeutics stock sinks further Tuesday after halting shipment of bestselling drug Elevidys

Sarepta stock tanked Friday after a new patient death was uncovered, spurring an FDA request to halt shipments of an ...

BioPharma Dive7d

5 questions on Sarepta, the FDA and a Duchenne gene therapy crisis

While Sarepta has now consented to the FDA’s request to stop selling Elevidys, the company’s brief standoff with the agency ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results